Daetwyler Holding AG
0QNJ.IL
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.2B
Close$
Share Statistics
| Market cap | $2.20 Billion |
|---|---|
| Enterprise Value | $2.62 Billion |
| Dividend Yield | $3.20 (2.48%) |
| Earnings per Share | $- |
| Beta | 1.73 |
| Outstanding Shares | - |
Return
| Return on Equity | 34.52% |
|---|---|
| Return on Assets | 10.10% |
| Return on Invested Capital | 20.83% |
Valuation & Multiples
| P/E Ratio | 26.75 |
|---|---|
| PEG | 724.15 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.18 |
| Enterprise Value to EBIT | 14.01 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 1.56 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 23, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$580.90 M
Average shareholder expectationNext Earnings Call
Expected Date
February 11, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$561.70 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Daetwyler Holding AG
7,823 employees
CEO: Volker Cwielong Dätwyler Holding AG engages in the provision of supply of system-critical elastomer components for injectable drug delivery systems. It operates through the Healthcare Solutions and Industrial Solutions segments. The Healthcare Solutions...